Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease

Wubshet H Tesfaye, Gregory M Peterson, Ronald L Castelino, Charlotte McKercher, Matthew Jose, Syed Tabish R Zaidi, Barbara C Wimmer

Research output: Contribution to journalArticle

Abstract

This study aimed to examine the association between medication-related factors and risk of hospital readmission in older patients with chronic kidney disease (CKD). A retrospective analysis was conducted targeting older CKD (n = 204) patients admitted to an Australian hospital. Medication appropriateness (Medication Appropriateness Index; MAI), medication regimen complexity (number of medications and Medication Regimen Complexity Index; MRCI) and use of selected medication classes were exposure variables. Outcomes were occurrence of readmission within 30 and 90 days, and time to readmission within 90 days. Logistic and Cox hazards regression were used to identify factors associated with readmission. Overall, 50 patients (24%) were readmitted within 30 days, while 81 (40%) were readmitted within 90 days. Mean time to readmission within 90 days was 66 (SD 34) days. Medication appropriateness and regimen complexity were not independently associated with 30- or 90-day hospital readmissions in older adults with CKD, whereas use of renin‒angiotensin blockers was associated with reduced occurrence of 30-day (adjusted OR 0.39; 95% CI 0.19⁻0.79) and 90-day readmissions (adjusted OR 0.45; 95% CI 0.24⁻0.84) and longer time to readmission within 90 days (adjusted HR 0.52; 95% CI 0.33⁻0.83). This finding highlights the importance of considering the potential benefits of individual medications during medication review in older CKD patients.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalJournal of Clinical Medicine
Volume8
Issue number3
DOIs
Publication statusPublished - 21 Mar 2019
Externally publishedYes

Fingerprint

Patient Readmission
Chronic Renal Insufficiency

Cite this

Tesfaye, W. H., Peterson, G. M., Castelino, R. L., McKercher, C., Jose, M., Zaidi, S. T. R., & Wimmer, B. C. (2019). Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease. Journal of Clinical Medicine, 8(3), 1-12. https://doi.org/10.3390/jcm8030395
Tesfaye, Wubshet H ; Peterson, Gregory M ; Castelino, Ronald L ; McKercher, Charlotte ; Jose, Matthew ; Zaidi, Syed Tabish R ; Wimmer, Barbara C. / Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease. In: Journal of Clinical Medicine. 2019 ; Vol. 8, No. 3. pp. 1-12.
@article{132f68d11dcc463689532c5f238147c4,
title = "Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease",
abstract = "This study aimed to examine the association between medication-related factors and risk of hospital readmission in older patients with chronic kidney disease (CKD). A retrospective analysis was conducted targeting older CKD (n = 204) patients admitted to an Australian hospital. Medication appropriateness (Medication Appropriateness Index; MAI), medication regimen complexity (number of medications and Medication Regimen Complexity Index; MRCI) and use of selected medication classes were exposure variables. Outcomes were occurrence of readmission within 30 and 90 days, and time to readmission within 90 days. Logistic and Cox hazards regression were used to identify factors associated with readmission. Overall, 50 patients (24{\%}) were readmitted within 30 days, while 81 (40{\%}) were readmitted within 90 days. Mean time to readmission within 90 days was 66 (SD 34) days. Medication appropriateness and regimen complexity were not independently associated with 30- or 90-day hospital readmissions in older adults with CKD, whereas use of renin‒angiotensin blockers was associated with reduced occurrence of 30-day (adjusted OR 0.39; 95{\%} CI 0.19⁻0.79) and 90-day readmissions (adjusted OR 0.45; 95{\%} CI 0.24⁻0.84) and longer time to readmission within 90 days (adjusted HR 0.52; 95{\%} CI 0.33⁻0.83). This finding highlights the importance of considering the potential benefits of individual medications during medication review in older CKD patients.",
author = "Tesfaye, {Wubshet H} and Peterson, {Gregory M} and Castelino, {Ronald L} and Charlotte McKercher and Matthew Jose and Zaidi, {Syed Tabish R} and Wimmer, {Barbara C}",
year = "2019",
month = "3",
day = "21",
doi = "10.3390/jcm8030395",
language = "English",
volume = "8",
pages = "1--12",
journal = "Journal of Clinical Medicine",
issn = "2077-0383",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

Tesfaye, WH, Peterson, GM, Castelino, RL, McKercher, C, Jose, M, Zaidi, STR & Wimmer, BC 2019, 'Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease', Journal of Clinical Medicine, vol. 8, no. 3, pp. 1-12. https://doi.org/10.3390/jcm8030395

Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease. / Tesfaye, Wubshet H; Peterson, Gregory M; Castelino, Ronald L; McKercher, Charlotte; Jose, Matthew; Zaidi, Syed Tabish R; Wimmer, Barbara C.

In: Journal of Clinical Medicine, Vol. 8, No. 3, 21.03.2019, p. 1-12.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease

AU - Tesfaye, Wubshet H

AU - Peterson, Gregory M

AU - Castelino, Ronald L

AU - McKercher, Charlotte

AU - Jose, Matthew

AU - Zaidi, Syed Tabish R

AU - Wimmer, Barbara C

PY - 2019/3/21

Y1 - 2019/3/21

N2 - This study aimed to examine the association between medication-related factors and risk of hospital readmission in older patients with chronic kidney disease (CKD). A retrospective analysis was conducted targeting older CKD (n = 204) patients admitted to an Australian hospital. Medication appropriateness (Medication Appropriateness Index; MAI), medication regimen complexity (number of medications and Medication Regimen Complexity Index; MRCI) and use of selected medication classes were exposure variables. Outcomes were occurrence of readmission within 30 and 90 days, and time to readmission within 90 days. Logistic and Cox hazards regression were used to identify factors associated with readmission. Overall, 50 patients (24%) were readmitted within 30 days, while 81 (40%) were readmitted within 90 days. Mean time to readmission within 90 days was 66 (SD 34) days. Medication appropriateness and regimen complexity were not independently associated with 30- or 90-day hospital readmissions in older adults with CKD, whereas use of renin‒angiotensin blockers was associated with reduced occurrence of 30-day (adjusted OR 0.39; 95% CI 0.19⁻0.79) and 90-day readmissions (adjusted OR 0.45; 95% CI 0.24⁻0.84) and longer time to readmission within 90 days (adjusted HR 0.52; 95% CI 0.33⁻0.83). This finding highlights the importance of considering the potential benefits of individual medications during medication review in older CKD patients.

AB - This study aimed to examine the association between medication-related factors and risk of hospital readmission in older patients with chronic kidney disease (CKD). A retrospective analysis was conducted targeting older CKD (n = 204) patients admitted to an Australian hospital. Medication appropriateness (Medication Appropriateness Index; MAI), medication regimen complexity (number of medications and Medication Regimen Complexity Index; MRCI) and use of selected medication classes were exposure variables. Outcomes were occurrence of readmission within 30 and 90 days, and time to readmission within 90 days. Logistic and Cox hazards regression were used to identify factors associated with readmission. Overall, 50 patients (24%) were readmitted within 30 days, while 81 (40%) were readmitted within 90 days. Mean time to readmission within 90 days was 66 (SD 34) days. Medication appropriateness and regimen complexity were not independently associated with 30- or 90-day hospital readmissions in older adults with CKD, whereas use of renin‒angiotensin blockers was associated with reduced occurrence of 30-day (adjusted OR 0.39; 95% CI 0.19⁻0.79) and 90-day readmissions (adjusted OR 0.45; 95% CI 0.24⁻0.84) and longer time to readmission within 90 days (adjusted HR 0.52; 95% CI 0.33⁻0.83). This finding highlights the importance of considering the potential benefits of individual medications during medication review in older CKD patients.

U2 - 10.3390/jcm8030395

DO - 10.3390/jcm8030395

M3 - Article

VL - 8

SP - 1

EP - 12

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

SN - 2077-0383

IS - 3

ER -